Institutional investors purchased a net $1.1 million shares of TXMD during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 48.18% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GILDER, GAGNON, HOWE & CO. LLC Bought 4.3 Million shares of TherapeuticsMD Inc
THE VANGUARD GROUP, INC. Bought 885.7 Thousand shares of TherapeuticsMD Inc
VHCP MANAGEMENT LLC Bought 846.5 Thousand shares of TherapeuticsMD Inc